Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_assertion type Assertion NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_head.
- NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_assertion description "[Further analysis of haplotype combinations demonstrated that drug-resistant patients tended to have the CGC/CGC, CGC/TGC, CGC/TTT, and TGC/TTT haplotype combinations over the seizure-free patients and controls (all p-values < 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_provenance.
- NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_assertion evidence source_evidence_literature NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_provenance.
- NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_assertion SIO_000772 16004559 NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_provenance.
- NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_assertion wasDerivedFrom befree-20140225 NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_provenance.
- NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_assertion wasGeneratedBy ECO_0000203 NP538679.RAOrzvubgQuAx1LdfWMk8836FL6iq3BG5lfnE2tlKVZ5w130_provenance.